

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.84726417 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.84726417 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.47155703 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.47155703 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30319718 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.29113546 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.93959495 |
| 8 | tryptophan catabolic process (GO:0006569) | 4.74468117 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 4.74468117 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 4.74468117 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.74349192 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.73299330 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.50028314 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.47761681 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46189042 |
| 16 | lysine metabolic process (GO:0006553) | 4.41382264 |
| 17 | lysine catabolic process (GO:0006554) | 4.41382264 |
| 18 | negative regulation of cell killing (GO:0031342) | 4.39696474 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39696474 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.32833026 |
| 21 | complement activation, alternative pathway (GO:0006957) | 4.32740687 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.28102527 |
| 23 | urea metabolic process (GO:0019627) | 4.18892706 |
| 24 | urea cycle (GO:0000050) | 4.18892706 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.17429780 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.08252866 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 3.98540435 |
| 28 | regulation of protein activation cascade (GO:2000257) | 3.96699710 |
| 29 | oxaloacetate metabolic process (GO:0006107) | 3.94956694 |
| 30 | protein carboxylation (GO:0018214) | 3.88982402 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.88982402 |
| 32 | bile acid metabolic process (GO:0008206) | 3.88703132 |
| 33 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85639986 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 3.82965447 |
| 35 | glutamate metabolic process (GO:0006536) | 3.82670708 |
| 36 | cysteine metabolic process (GO:0006534) | 3.82349679 |
| 37 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.81466628 |
| 38 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.81466628 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.79057028 |
| 40 | coenzyme catabolic process (GO:0009109) | 3.76643913 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.74748329 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.74748329 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74748329 |
| 44 | regulation of complement activation (GO:0030449) | 3.73593111 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.73581353 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.71839626 |
| 47 | ketone body metabolic process (GO:1902224) | 3.69699722 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69093079 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 3.67976192 |
| 50 | reverse cholesterol transport (GO:0043691) | 3.66760158 |
| 51 | phospholipid efflux (GO:0033700) | 3.65437872 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 3.65200123 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.61944425 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.59503117 |
| 55 | ethanol oxidation (GO:0006069) | 3.57397159 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55205059 |
| 57 | tyrosine metabolic process (GO:0006570) | 3.53279877 |
| 58 | negative regulation of sterol transport (GO:0032372) | 3.50551488 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.50551488 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 3.49199585 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48243342 |
| 62 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46192023 |
| 63 | succinate metabolic process (GO:0006105) | 3.43764630 |
| 64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41691203 |
| 65 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41691203 |
| 66 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41691203 |
| 67 | modulation by symbiont of host immune response (GO:0052553) | 3.41691203 |
| 68 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41691203 |
| 69 | modulation by symbiont of host defense response (GO:0052031) | 3.41691203 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.41644402 |
| 71 | acylglycerol homeostasis (GO:0055090) | 3.40538887 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.40538887 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37189834 |
| 74 | response to peptidoglycan (GO:0032494) | 3.33939813 |
| 75 | peroxisome fission (GO:0016559) | 3.33854768 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.29703028 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 3.26488097 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.26413098 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 3.25724769 |
| 80 | homocysteine metabolic process (GO:0050667) | 3.25100750 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.24879085 |
| 82 | cofactor catabolic process (GO:0051187) | 3.24666377 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.24595396 |
| 84 | dicarboxylic acid catabolic process (GO:0043649) | 3.23462143 |
| 85 | regulation of gamma-delta T cell activation (GO:0046643) | 3.22496330 |
| 86 | NADH metabolic process (GO:0006734) | 3.21106051 |
| 87 | mannose metabolic process (GO:0006013) | 3.20347773 |
| 88 | serine family amino acid catabolic process (GO:0009071) | 3.19865214 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.19610158 |
| 90 | cholesterol efflux (GO:0033344) | 3.18369853 |
| 91 | tolerance induction (GO:0002507) | 3.18185688 |
| 92 | regulation of mast cell degranulation (GO:0043304) | 3.17917199 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.16713578 |
| 94 | imidazole-containing compound metabolic process (GO:0052803) | 3.15414114 |
| 95 | disruption of cells of other organism (GO:0044364) | 3.12257630 |
| 96 | killing of cells of other organism (GO:0031640) | 3.12257630 |
| 97 | plasma lipoprotein particle clearance (GO:0034381) | 3.10963587 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.10590961 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 3.08652772 |
| 100 | complement activation (GO:0006956) | 3.08282749 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07760737 |
| 102 | aldehyde catabolic process (GO:0046185) | 3.06667035 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.06285641 |
| 104 | organic acid catabolic process (GO:0016054) | 3.06285641 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 3.05280606 |
| 106 | amine catabolic process (GO:0009310) | 3.05280606 |
| 107 | complement activation, classical pathway (GO:0006958) | 3.04942151 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.02306979 |
| 109 | cytolysis (GO:0019835) | 3.02114156 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.01088363 |
| 111 | arginine metabolic process (GO:0006525) | 3.00230482 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.99595899 |
| 113 | NAD metabolic process (GO:0019674) | 2.99316099 |
| 114 | plasma lipoprotein particle assembly (GO:0034377) | 2.98840664 |
| 115 | cholesterol catabolic process (GO:0006707) | 2.98074215 |
| 116 | sterol catabolic process (GO:0016127) | 2.98074215 |
| 117 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97701594 |
| 118 | fatty acid catabolic process (GO:0009062) | 2.97246713 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.97216682 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.97216682 |
| 121 | drug catabolic process (GO:0042737) | 2.97193266 |
| 122 | opsonization (GO:0008228) | 2.96513388 |
| 123 | phospholipid homeostasis (GO:0055091) | 2.95588878 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 2.95324030 |
| 125 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94473370 |
| 126 | germinal center formation (GO:0002467) | 2.92176631 |
| 127 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91026739 |
| 128 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89757643 |
| 129 | barbed-end actin filament capping (GO:0051016) | 2.83605176 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.79985190 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.77806282 |
| 132 | response to type I interferon (GO:0034340) | 2.77787633 |
| 133 | type I interferon signaling pathway (GO:0060337) | 2.77472102 |
| 134 | cellular response to type I interferon (GO:0071357) | 2.77472102 |
| 135 | detection of bacterium (GO:0016045) | 2.77444520 |
| 136 | modulation by virus of host process (GO:0019054) | 2.70778049 |
| 137 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70761506 |
| 138 | detection of other organism (GO:0098543) | 2.67857438 |
| 139 | thymic T cell selection (GO:0045061) | 2.66059014 |
| 140 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62027068 |
| 141 | macrophage activation involved in immune response (GO:0002281) | 2.58959460 |
| 142 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58496912 |
| 143 | modulation by symbiont of host cellular process (GO:0044068) | 2.57936904 |
| 144 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.56287810 |
| 145 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51022228 |
| 146 | neutrophil activation (GO:0042119) | 2.50498408 |
| 147 | negative regulation of innate immune response (GO:0045824) | 2.49485457 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.48350424 |
| 149 | regulation of autophagic vacuole assembly (GO:2000785) | 2.47667045 |
| 150 | response to host immune response (GO:0052572) | 2.45135227 |
| 151 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45135227 |
| 152 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.45012462 |
| 153 | granulocyte activation (GO:0036230) | 2.44748074 |
| 154 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43755331 |
| 155 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.41818501 |
| 156 | T cell selection (GO:0045058) | 2.41660959 |
| 157 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36880188 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.34013036 |
| 159 | regulation of regulated secretory pathway (GO:1903305) | 2.33616185 |
| 160 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.33586181 |
| 161 | negative regulation of type 2 immune response (GO:0002829) | 2.32276464 |
| 162 | stress fiber assembly (GO:0043149) | 2.31597798 |
| 163 | diacylglycerol metabolic process (GO:0046339) | 2.31320682 |
| 164 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31272638 |
| 165 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.30381699 |
| 166 | actin filament polymerization (GO:0030041) | 2.30344981 |
| 167 | detection of external biotic stimulus (GO:0098581) | 2.30304718 |
| 168 | regulation of vacuole organization (GO:0044088) | 2.27789236 |
| 169 | regulation of podosome assembly (GO:0071801) | 2.27457132 |
| 170 | negative regulation of interleukin-6 production (GO:0032715) | 2.27387479 |
| 171 | regulation of type 2 immune response (GO:0002828) | 2.27088962 |
| 172 | response to host (GO:0075136) | 2.26979992 |
| 173 | response to host defenses (GO:0052200) | 2.26979992 |
| 174 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.26979992 |
| 175 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.26784565 |
| 176 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.26557274 |
| 177 | positive regulation of type 2 immune response (GO:0002830) | 2.26429732 |
| 178 | regulation of mast cell activation (GO:0033003) | 2.25913724 |
| 179 | protein localization to endosome (GO:0036010) | 2.24521221 |
| 180 | regulation of antigen processing and presentation (GO:0002577) | 2.24397453 |
| 181 | negative thymic T cell selection (GO:0045060) | 2.23567404 |
| 182 | defense response to protozoan (GO:0042832) | 2.23278720 |
| 183 | negative regulation of cell size (GO:0045792) | 2.23274983 |
| 184 | leukocyte aggregation (GO:0070486) | 2.23220641 |
| 185 | regulation of ARF GTPase activity (GO:0032312) | 2.20662644 |
| 186 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.19914356 |
| 187 | positive thymic T cell selection (GO:0045059) | 2.18076188 |
| 188 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.17828841 |
| 189 | regulation of defense response to virus by virus (GO:0050690) | 2.16982798 |
| 190 | response to protozoan (GO:0001562) | 2.16403043 |
| 191 | positive regulation of antigen processing and presentation (GO:0002579) | 2.15220609 |
| 192 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.14227048 |
| 193 | peptide catabolic process (GO:0043171) | 2.14173060 |
| 194 | myeloid cell activation involved in immune response (GO:0002275) | 2.14113001 |
| 195 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.13123328 |
| 196 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.13093483 |
| 197 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.12903981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.83425335 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.03705431 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.22130973 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.50327208 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29198187 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.08715011 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.99129873 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.64301596 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.01936949 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.89031331 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75343034 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.40112658 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36308400 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.22744583 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19196043 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14873525 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14638619 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.09975115 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.09081186 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05647525 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00940713 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.99151818 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94496409 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89796487 |
| 25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89187284 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83065275 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83038620 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78178980 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70513034 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69948056 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.67671738 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67064351 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64084151 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62643833 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59559189 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58975083 |
| 37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58302008 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54845336 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54765684 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.53121903 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49228630 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45641454 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45140842 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43702667 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38993739 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38438236 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36831654 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36749625 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30345583 |
| 50 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28700344 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27847700 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.26942226 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26266783 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26118122 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23878157 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23690909 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23229539 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23078797 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22526051 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22290692 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21471152 |
| 62 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20133453 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18878108 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18309488 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18020522 |
| 66 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.17371086 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16838563 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16073350 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15669643 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15492009 |
| 71 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13482878 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12995315 |
| 73 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12650485 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11890708 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11865161 |
| 76 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11605758 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11207555 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10538084 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10304506 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 1.09656662 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08843542 |
| 82 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.08643658 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07524282 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07254803 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07114160 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06278247 |
| 87 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06246496 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05789204 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05204128 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03773614 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03288799 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03210798 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02879440 |
| 94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02255633 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97673517 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97211894 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96421334 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96385719 |
| 99 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96107939 |
| 100 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95352307 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94896851 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93840773 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93327349 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92576029 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88913122 |
| 106 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88820933 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86775701 |
| 108 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83851652 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81691647 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81064552 |
| 111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81010460 |
| 112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80714961 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80698774 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79917003 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79086717 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77333274 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76918796 |
| 118 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76518041 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 0.75833938 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75221315 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.74660884 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74543161 |
| 123 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.74432734 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74430573 |
| 125 | UTX_26944678_Chip-Seq_JUKART_Human | 0.73446542 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72736098 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72639461 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72505209 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 0.72416165 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71431623 |
| 131 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.71255176 |
| 132 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.70588049 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70539141 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70243570 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70202024 |
| 136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69839903 |
| 137 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.69723593 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69622418 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69153115 |
| 140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69029283 |
| 141 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.68711518 |
| 142 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67476604 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.66387286 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65757007 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.65718959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.28854271 |
| 2 | MP0005360_urolithiasis | 5.81286088 |
| 3 | MP0005365_abnormal_bile_salt | 4.97026127 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.82387159 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.05445375 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.17012338 |
| 7 | MP0009840_abnormal_foam_cell | 2.79384682 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.73335280 |
| 9 | MP0003252_abnormal_bile_duct | 2.70104193 |
| 10 | MP0005083_abnormal_biliary_tract | 2.45387808 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.35835913 |
| 12 | MP0005332_abnormal_amino_acid | 2.27625971 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.16666012 |
| 14 | MP0003195_calcinosis | 2.09000269 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.08266044 |
| 16 | MP0002822_catalepsy | 2.08253707 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.03176627 |
| 18 | MP0009278_abnormal_bone_marrow | 2.01227501 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.90273499 |
| 20 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.89574424 |
| 21 | MP0008004_abnormal_stomach_pH | 1.85396428 |
| 22 | MP0000609_abnormal_liver_physiology | 1.85051732 |
| 23 | MP0008260_abnormal_autophagy | 1.77258067 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.74756342 |
| 25 | MP0000604_amyloidosis | 1.71865905 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.69521773 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.67927468 |
| 28 | MP0001819_abnormal_immune_cell | 1.67584847 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.66184136 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.66184136 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.65710424 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.65496705 |
| 33 | MP0003329_amyloid_beta_deposits | 1.64250273 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.63064688 |
| 35 | MP0002254_reproductive_system_inflammat | 1.60698652 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.59881829 |
| 37 | MP0004947_skin_inflammation | 1.58592410 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.56398843 |
| 39 | MP0004858_abnormal_nervous_system | 1.55394302 |
| 40 | MP0001764_abnormal_homeostasis | 1.54305420 |
| 41 | MP0004510_myositis | 1.48785099 |
| 42 | MP0001873_stomach_inflammation | 1.47479060 |
| 43 | MP0001849_ear_inflammation | 1.40948518 |
| 44 | MP0003436_decreased_susceptibility_to | 1.40500299 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.39723211 |
| 46 | MP0002132_abnormal_respiratory_system | 1.38903777 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.38604202 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.38006957 |
| 49 | MP0003866_abnormal_defecation | 1.37860071 |
| 50 | MP0004381_abnormal_hair_follicle | 1.37477874 |
| 51 | MP0004264_abnormal_extraembryonic_tissu | 1.36817115 |
| 52 | MP0000716_abnormal_immune_system | 1.35051119 |
| 53 | MP0003868_abnormal_feces_composition | 1.33833292 |
| 54 | MP0002405_respiratory_system_inflammati | 1.33684162 |
| 55 | MP0002398_abnormal_bone_marrow | 1.29082445 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.26122425 |
| 57 | MP0005535_abnormal_body_temperature | 1.24836850 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.24817484 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.22265340 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.20955832 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.20688956 |
| 62 | MP0009785_altered_susceptibility_to | 1.19408674 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.16257126 |
| 64 | MP0005451_abnormal_body_composition | 1.16216652 |
| 65 | MP0003075_altered_response_to | 1.14331487 |
| 66 | MP0000858_altered_metastatic_potential | 1.13942515 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.12700582 |
| 68 | MP0008469_abnormal_protein_level | 1.12145516 |
| 69 | MP0004130_abnormal_muscle_cell | 1.11755740 |
| 70 | MP0002429_abnormal_blood_cell | 1.09873667 |
| 71 | MP0009697_abnormal_copulation | 1.09698261 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.09660486 |
| 73 | MP0002722_abnormal_immune_system | 1.09487815 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.08384943 |
| 75 | MP0009764_decreased_sensitivity_to | 1.07535513 |
| 76 | MP0003724_increased_susceptibility_to | 1.06638231 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.05548704 |
| 78 | MP0003279_aneurysm | 1.05062215 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 1.03506581 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 1.03117668 |
| 81 | MP0008874_decreased_physiological_sensi | 1.02490654 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.02323103 |
| 83 | MP0001835_abnormal_antigen_presentation | 1.01653526 |
| 84 | MP0005310_abnormal_salivary_gland | 1.01455866 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.99558592 |
| 86 | MP0000598_abnormal_liver_morphology | 0.99068020 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.97610036 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.96642015 |
| 89 | MP0005646_abnormal_pituitary_gland | 0.96329977 |
| 90 | MP0002933_joint_inflammation | 0.94625370 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.94486228 |
| 92 | MP0005448_abnormal_energy_balance | 0.93081677 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.93018310 |
| 94 | MP0006082_CNS_inflammation | 0.92522053 |
| 95 | MP0005166_decreased_susceptibility_to | 0.91155087 |
| 96 | MP0005025_abnormal_response_to | 0.90602538 |
| 97 | MP0002419_abnormal_innate_immunity | 0.90191347 |
| 98 | MP0002064_seizures | 0.90124193 |
| 99 | MP0005409_darkened_coat_color | 0.89717655 |
| 100 | MP0009763_increased_sensitivity_to | 0.89605242 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.89453544 |
| 102 | MP0000343_altered_response_to | 0.88780782 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.88752043 |
| 104 | MP0003633_abnormal_nervous_system | 0.87336748 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.86474892 |
| 106 | MP0001663_abnormal_digestive_system | 0.85962813 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.85209902 |
| 108 | MP0000490_abnormal_crypts_of | 0.84583283 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.83169542 |
| 110 | MP0005390_skeleton_phenotype | 0.82611688 |
| 111 | MP0002063_abnormal_learning/memory/cond | 0.81953441 |
| 112 | MP0003690_abnormal_glial_cell | 0.81369359 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.80722720 |
| 114 | MP0003186_abnormal_redox_activity | 0.80497454 |
| 115 | MP0003879_abnormal_hair_cell | 0.80103497 |
| 116 | MP0009745_abnormal_behavioral_response | 0.79794263 |
| 117 | MP0000685_abnormal_immune_system | 0.79367731 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.78680138 |
| 119 | MP0001664_abnormal_digestion | 0.78632474 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.78528146 |
| 121 | MP0005671_abnormal_response_to | 0.78475056 |
| 122 | MP0003303_peritoneal_inflammation | 0.77917247 |
| 123 | MP0003705_abnormal_hypodermis_morpholog | 0.77199330 |
| 124 | MP0003795_abnormal_bone_structure | 0.76402484 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.75593185 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.74300427 |
| 127 | MP0008872_abnormal_physiological_respon | 0.73505206 |
| 128 | MP0003011_delayed_dark_adaptation | 0.73379817 |
| 129 | MP0005376_homeostasis/metabolism_phenot | 0.73336830 |
| 130 | MP0001790_abnormal_immune_system | 0.71534023 |
| 131 | MP0005387_immune_system_phenotype | 0.71534023 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.71370260 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.70771233 |
| 134 | MP0001853_heart_inflammation | 0.69598523 |
| 135 | MP0001984_abnormal_olfaction | 0.69493580 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.68197824 |
| 137 | MP0009046_muscle_twitch | 0.66885857 |
| 138 | MP0001800_abnormal_humoral_immune | 0.66377435 |
| 139 | MP0002572_abnormal_emotion/affect_behav | 0.66331501 |
| 140 | MP0000249_abnormal_blood_vessel | 0.65741870 |
| 141 | MP0001756_abnormal_urination | 0.63921338 |
| 142 | MP0005000_abnormal_immune_tolerance | 0.63821623 |
| 143 | MP0003953_abnormal_hormone_level | 0.63584363 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.62743210 |
| 145 | MP0005334_abnormal_fat_pad | 0.62179518 |
| 146 | MP0003763_abnormal_thymus_physiology | 0.61676850 |
| 147 | MP0002971_abnormal_brown_adipose | 0.61497211 |
| 148 | MP0001533_abnormal_skeleton_physiology | 0.61386438 |
| 149 | MP0002723_abnormal_immune_serum | 0.61112726 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.60475266 |
| 151 | MP0002090_abnormal_vision | 0.60266312 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.59051861 |
| 153 | MP0005670_abnormal_white_adipose | 0.58916360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.50495910 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.40983716 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.62826869 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.54035773 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.52589720 |
| 6 | Xanthomatosis (HP:0000991) | 4.51394587 |
| 7 | Complement deficiency (HP:0004431) | 4.29048447 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.27517362 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.18047487 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.92539788 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.81536224 |
| 12 | Ketosis (HP:0001946) | 3.81001637 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.75480372 |
| 14 | Purpura (HP:0000979) | 3.68837409 |
| 15 | Hyperammonemia (HP:0001987) | 3.62433978 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.56245816 |
| 17 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55796419 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.54746075 |
| 19 | Joint hemorrhage (HP:0005261) | 3.51890902 |
| 20 | Petechiae (HP:0000967) | 3.51187333 |
| 21 | Stomatitis (HP:0010280) | 3.42278166 |
| 22 | Myositis (HP:0100614) | 3.37879764 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35380980 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.34720287 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.32256689 |
| 26 | Loss of speech (HP:0002371) | 3.25332391 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.22723561 |
| 28 | Hyperbilirubinemia (HP:0002904) | 3.19334714 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.17792519 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.16726829 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.16476626 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.13256487 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12467376 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12467376 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12467376 |
| 36 | Abnormality of complement system (HP:0005339) | 3.11995058 |
| 37 | Orchitis (HP:0100796) | 3.11344212 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07630286 |
| 39 | Ketoacidosis (HP:0001993) | 3.05652769 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96868352 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.94463703 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.93323714 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.92998209 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91789374 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.90328246 |
| 46 | Epidermoid cyst (HP:0200040) | 2.87560499 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86574071 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86574071 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86574071 |
| 50 | Fat malabsorption (HP:0002630) | 2.85728892 |
| 51 | Gout (HP:0001997) | 2.80038273 |
| 52 | Cholecystitis (HP:0001082) | 2.74000244 |
| 53 | Abnormal gallbladder physiology (HP:0012438) | 2.74000244 |
| 54 | Hyperglycinemia (HP:0002154) | 2.73018610 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.70894059 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69518966 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.69518966 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.68822032 |
| 59 | Optic neuritis (HP:0100653) | 2.68090743 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.68090743 |
| 61 | Abnormality of methionine metabolism (HP:0010901) | 2.60768187 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60110166 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.59778684 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59152163 |
| 65 | Cholelithiasis (HP:0001081) | 2.58940091 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.57949999 |
| 67 | Mitral stenosis (HP:0001718) | 2.55995218 |
| 68 | Obstructive lung disease (HP:0006536) | 2.53665333 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53665333 |
| 70 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.53332114 |
| 71 | Abnormality of glycine metabolism (HP:0010895) | 2.48846307 |
| 72 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48846307 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.47483615 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.46731197 |
| 75 | Thin bony cortex (HP:0002753) | 2.46531021 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.46305949 |
| 77 | Metabolic acidosis (HP:0001942) | 2.45256423 |
| 78 | Hyperglycinuria (HP:0003108) | 2.44634461 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 2.43710620 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.40251834 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.39835553 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35822422 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.35822422 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.34564861 |
| 85 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34365361 |
| 86 | Bulbar palsy (HP:0001283) | 2.32197420 |
| 87 | Glomerulonephritis (HP:0000099) | 2.28012555 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.27036492 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.26293536 |
| 90 | Vasculitis (HP:0002633) | 2.25864378 |
| 91 | Gingivitis (HP:0000230) | 2.25620168 |
| 92 | Distal lower limb muscle weakness (HP:0009053) | 2.25603198 |
| 93 | Increased serum ferritin (HP:0003281) | 2.24922663 |
| 94 | Gastrointestinal inflammation (HP:0004386) | 2.23832321 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.22880948 |
| 96 | J-shaped sella turcica (HP:0002680) | 2.22344516 |
| 97 | Axonal loss (HP:0003447) | 2.21431437 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 2.21313017 |
| 99 | Malnutrition (HP:0004395) | 2.20749523 |
| 100 | Steatorrhea (HP:0002570) | 2.19966823 |
| 101 | Cellulitis (HP:0100658) | 2.19351792 |
| 102 | Neonatal onset (HP:0003623) | 2.19097724 |
| 103 | Hyperventilation (HP:0002883) | 2.17734825 |
| 104 | Pustule (HP:0200039) | 2.16485739 |
| 105 | Late onset (HP:0003584) | 2.15852995 |
| 106 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15674843 |
| 107 | Meningitis (HP:0001287) | 2.15383258 |
| 108 | Death in childhood (HP:0003819) | 2.15166633 |
| 109 | Increased IgE level (HP:0003212) | 2.14360828 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 2.10424147 |
| 111 | Gingival bleeding (HP:0000225) | 2.10103728 |
| 112 | Clumsiness (HP:0002312) | 2.08307253 |
| 113 | Spastic diplegia (HP:0001264) | 2.08274829 |
| 114 | Easy fatigability (HP:0003388) | 2.08041910 |
| 115 | Brushfield spots (HP:0001088) | 2.07325153 |
| 116 | Myopathic facies (HP:0002058) | 2.07144560 |
| 117 | Inflammation of the large intestine (HP:0002037) | 2.06757805 |
| 118 | Pulmonary embolism (HP:0002204) | 2.06635361 |
| 119 | Granulocytopenia (HP:0001913) | 2.06469043 |
| 120 | Thrombophlebitis (HP:0004418) | 2.06439846 |
| 121 | Recurrent skin infections (HP:0001581) | 2.06295711 |
| 122 | Stridor (HP:0010307) | 2.06115436 |
| 123 | Gastrointestinal stroma tumor (HP:0100723) | 2.03036320 |
| 124 | Abnormality of the columella (HP:0009929) | 2.01781879 |
| 125 | Spontaneous abortion (HP:0005268) | 2.01395248 |
| 126 | Lethargy (HP:0001254) | 2.00595795 |
| 127 | Hepatocellular carcinoma (HP:0001402) | 2.00494506 |
| 128 | Hypophosphatemia (HP:0002148) | 1.99698333 |
| 129 | Status epilepticus (HP:0002133) | 1.99651926 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.99258246 |
| 131 | Irritability (HP:0000737) | 1.98104307 |
| 132 | Disinhibition (HP:0000734) | 1.97182226 |
| 133 | Obstructive sleep apnea (HP:0002870) | 1.96330247 |
| 134 | Opisthotonus (HP:0002179) | 1.95666343 |
| 135 | Epistaxis (HP:0000421) | 1.94342028 |
| 136 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94320085 |
| 137 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94320085 |
| 138 | Keratoconjunctivitis sicca (HP:0001097) | 1.94225703 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.93347559 |
| 140 | Ankle clonus (HP:0011448) | 1.91912231 |
| 141 | Keratoconjunctivitis (HP:0001096) | 1.91382172 |
| 142 | Skin nodule (HP:0200036) | 1.91140002 |
| 143 | Colitis (HP:0002583) | 1.90963659 |
| 144 | Abnormality of the nasal mucosa (HP:0000433) | 1.90306170 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.89356136 |
| 146 | Epiphyseal stippling (HP:0010655) | 1.88185310 |
| 147 | Oligomenorrhea (HP:0000876) | 1.87135663 |
| 148 | Neuronal loss in central nervous system (HP:0002529) | 1.86738903 |
| 149 | Increased IgM level (HP:0003496) | 1.86175215 |
| 150 | Pancreatitis (HP:0001733) | 1.86051216 |
| 151 | Neuroendocrine neoplasm (HP:0100634) | 1.86038363 |
| 152 | Vomiting (HP:0002013) | 1.85516717 |
| 153 | Abnormality of serum amino acid levels (HP:0003112) | 1.85206540 |
| 154 | Emphysema (HP:0002097) | 1.84341589 |
| 155 | Flat acetabular roof (HP:0003180) | 1.84179145 |
| 156 | Craniofacial dystonia (HP:0012179) | 1.84097665 |
| 157 | Vertebral compression fractures (HP:0002953) | 1.83225870 |
| 158 | Abnormality of the costochondral junction (HP:0000919) | 1.82728294 |
| 159 | Polycythemia (HP:0001901) | 1.82617828 |
| 160 | Mutism (HP:0002300) | 1.81957718 |
| 161 | Hypertriglyceridemia (HP:0002155) | 1.81757235 |
| 162 | Cerebral edema (HP:0002181) | 1.81162778 |
| 163 | Encephalitis (HP:0002383) | 1.80145705 |
| 164 | Exercise-induced myalgia (HP:0003738) | 1.79898044 |
| 165 | Abnormality of iron homeostasis (HP:0011031) | 1.79629145 |
| 166 | Acne (HP:0001061) | 1.79541069 |
| 167 | Hemoptysis (HP:0002105) | 1.79365141 |
| 168 | Slow saccadic eye movements (HP:0000514) | 1.78891300 |
| 169 | Conjunctival hamartoma (HP:0100780) | 1.78870542 |
| 170 | Myocardial infarction (HP:0001658) | 1.77702589 |
| 171 | Focal dystonia (HP:0004373) | 1.77490784 |
| 172 | Visual hallucinations (HP:0002367) | 1.77140568 |
| 173 | Amyloidosis (HP:0011034) | 1.75334564 |
| 174 | Torticollis (HP:0000473) | 1.74409639 |
| 175 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.74143946 |
| 176 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.74143946 |
| 177 | Acute hepatic failure (HP:0006554) | 1.73664242 |
| 178 | Pheochromocytoma (HP:0002666) | 1.72458187 |
| 179 | Joint swelling (HP:0001386) | 1.72023618 |
| 180 | Menorrhagia (HP:0000132) | 1.71781259 |
| 181 | Hypoplasia of the thymus (HP:0000778) | 1.71146318 |
| 182 | Hepatic necrosis (HP:0002605) | 1.68019576 |
| 183 | Ragged-red muscle fibers (HP:0003200) | 1.66927487 |
| 184 | Myokymia (HP:0002411) | 1.63737081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.87834696 |
| 2 | ERN1 | 3.51622672 |
| 3 | MAP3K12 | 2.69887698 |
| 4 | MAP2K4 | 2.63768861 |
| 5 | MAP4K1 | 2.58127850 |
| 6 | PRPF4B | 2.43878511 |
| 7 | TRIB3 | 2.38603630 |
| 8 | DAPK2 | 2.17902172 |
| 9 | FGFR4 | 2.00516664 |
| 10 | ZAP70 | 1.94084677 |
| 11 | CAMKK1 | 1.93886154 |
| 12 | TAOK3 | 1.92555572 |
| 13 | PKN2 | 1.89792578 |
| 14 | DAPK1 | 1.87313296 |
| 15 | NME2 | 1.86849655 |
| 16 | IRAK3 | 1.83691366 |
| 17 | GRK6 | 1.78963655 |
| 18 | SMG1 | 1.75404070 |
| 19 | MARK3 | 1.71858024 |
| 20 | TAOK2 | 1.69885779 |
| 21 | TYK2 | 1.69741059 |
| 22 | TXK | 1.66553287 |
| 23 | MAP2K3 | 1.62720288 |
| 24 | MAP3K3 | 1.57663737 |
| 25 | EPHA4 | 1.55298062 |
| 26 | CAMKK2 | 1.53431160 |
| 27 | MAP3K4 | 1.49914036 |
| 28 | INSRR | 1.49718105 |
| 29 | SIK1 | 1.49091976 |
| 30 | EPHB1 | 1.40201410 |
| 31 | FES | 1.39001468 |
| 32 | MAP3K14 | 1.37685973 |
| 33 | CDK19 | 1.37157787 |
| 34 | TBK1 | 1.32646452 |
| 35 | MAP2K7 | 1.32300573 |
| 36 | PRKCH | 1.30310122 |
| 37 | MAPKAPK3 | 1.28718976 |
| 38 | PRKD2 | 1.28308685 |
| 39 | JAK1 | 1.27892142 |
| 40 | FLT3 | 1.24147911 |
| 41 | EEF2K | 1.23311251 |
| 42 | MINK1 | 1.20654084 |
| 43 | CDC42BPA | 1.18753558 |
| 44 | PIM2 | 1.18313087 |
| 45 | SIK3 | 1.17109930 |
| 46 | ICK | 1.16483677 |
| 47 | SYK | 1.14273368 |
| 48 | TESK1 | 1.13379368 |
| 49 | KDR | 1.12296066 |
| 50 | MAP3K6 | 1.11136845 |
| 51 | BTK | 1.06999215 |
| 52 | PDK3 | 1.04660005 |
| 53 | PDK4 | 1.04660005 |
| 54 | IRAK2 | 1.04565580 |
| 55 | MAP2K6 | 1.03758984 |
| 56 | KIT | 1.03417546 |
| 57 | MARK2 | 1.02543396 |
| 58 | TAOK1 | 1.01920015 |
| 59 | MAP3K7 | 1.00329656 |
| 60 | IKBKB | 1.00005214 |
| 61 | IKBKE | 0.99843579 |
| 62 | MAPK11 | 0.99345190 |
| 63 | MAPK12 | 0.99247712 |
| 64 | HIPK2 | 0.98358667 |
| 65 | JAK2 | 0.97808381 |
| 66 | ITK | 0.97251089 |
| 67 | STK38 | 0.96493198 |
| 68 | MAP3K11 | 0.96472989 |
| 69 | TGFBR2 | 0.96395067 |
| 70 | KSR2 | 0.92353747 |
| 71 | SGK3 | 0.91236403 |
| 72 | NTRK3 | 0.88403407 |
| 73 | MATK | 0.88352776 |
| 74 | EPHA2 | 0.88075926 |
| 75 | PINK1 | 0.88055944 |
| 76 | CDK12 | 0.85515552 |
| 77 | MAP3K13 | 0.85418703 |
| 78 | MAPK4 | 0.84409034 |
| 79 | RIPK4 | 0.84274335 |
| 80 | MUSK | 0.82205347 |
| 81 | RIPK1 | 0.79947477 |
| 82 | SGK2 | 0.79808189 |
| 83 | FGR | 0.79804452 |
| 84 | ARAF | 0.79527330 |
| 85 | MAP3K9 | 0.78811469 |
| 86 | RPS6KL1 | 0.77356221 |
| 87 | RPS6KC1 | 0.77356221 |
| 88 | BLK | 0.76529924 |
| 89 | RET | 0.75961887 |
| 90 | TESK2 | 0.75709568 |
| 91 | CSF1R | 0.74463433 |
| 92 | PRKG2 | 0.74284683 |
| 93 | MAP3K1 | 0.74221342 |
| 94 | CAMK4 | 0.72633396 |
| 95 | IRAK4 | 0.72622865 |
| 96 | MAP2K2 | 0.72186193 |
| 97 | SIK2 | 0.69201558 |
| 98 | PRKCG | 0.67956367 |
| 99 | DDR2 | 0.67538445 |
| 100 | PDK1 | 0.65981902 |
| 101 | CHUK | 0.63867433 |
| 102 | BMX | 0.63120485 |
| 103 | MAP3K10 | 0.62925304 |
| 104 | LRRK2 | 0.60514764 |
| 105 | SGK494 | 0.60442784 |
| 106 | SGK223 | 0.60442784 |
| 107 | IRAK1 | 0.59940601 |
| 108 | RPS6KA6 | 0.58958836 |
| 109 | PDPK1 | 0.57780022 |
| 110 | TNK2 | 0.56788422 |
| 111 | TYRO3 | 0.56670646 |
| 112 | MAPKAPK2 | 0.55254192 |
| 113 | NEK1 | 0.55163130 |
| 114 | RPS6KA2 | 0.54998048 |
| 115 | PTK6 | 0.54031691 |
| 116 | LYN | 0.52307298 |
| 117 | CDK5 | 0.52053561 |
| 118 | TGFBR1 | 0.51786629 |
| 119 | MTOR | 0.51496090 |
| 120 | LCK | 0.51317449 |
| 121 | ADRBK2 | 0.50879352 |
| 122 | JAK3 | 0.50686759 |
| 123 | PRKCZ | 0.50072516 |
| 124 | MAPK7 | 0.49654483 |
| 125 | PASK | 0.49533581 |
| 126 | MYLK | 0.49528159 |
| 127 | TEC | 0.49499290 |
| 128 | TIE1 | 0.47413517 |
| 129 | CCNB1 | 0.47244816 |
| 130 | CSK | 0.46182457 |
| 131 | DYRK1B | 0.45524209 |
| 132 | PRKACG | 0.45007140 |
| 133 | ERBB4 | 0.44756718 |
| 134 | PRKCQ | 0.44421080 |
| 135 | PTK2B | 0.44005780 |
| 136 | HCK | 0.43371956 |
| 137 | NTRK1 | 0.42574902 |
| 138 | MAP3K5 | 0.42210236 |
| 139 | TTN | 0.42023287 |
| 140 | RPS6KA1 | 0.40338916 |
| 141 | MARK1 | 0.39853598 |
| 142 | PRKD3 | 0.39759249 |
| 143 | CAMK1 | 0.39271793 |
| 144 | BRAF | 0.39249744 |
| 145 | FYN | 0.38825335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08741889 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.01567107 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.04377812 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84703880 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.81459875 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69551074 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65894234 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38240595 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31093606 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.30484359 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30230475 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22221506 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21664658 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.07822774 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05162614 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02107724 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.95602602 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89540031 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85159582 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82754705 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77242835 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76154371 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75275257 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.73102067 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70798285 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62844069 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62794107 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62512860 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61643848 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55862737 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53177208 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50034497 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47413562 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47208727 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47198504 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.45019238 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.43598474 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43126360 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41707923 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41184147 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.34846253 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32053241 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32040594 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.31783946 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31458234 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31352754 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30801888 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30381386 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.30014063 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29844415 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.27794672 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26428024 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23693922 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23482713 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23244658 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22987822 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21885892 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19135997 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.16372764 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15277595 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14835844 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11432693 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08650224 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08466019 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.08090432 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04098756 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 1.02120259 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.02051841 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01856452 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01614448 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00622854 |
| 72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98547106 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98038353 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96764035 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96453391 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.96412459 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96295385 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.95743333 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94499707 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94058770 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93512923 |
| 82 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91628245 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91598436 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91179404 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89960693 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89569828 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89125499 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.87995304 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.87416947 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86311223 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86296414 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86146004 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.85798566 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85487986 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83234887 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82385030 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81989236 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79652225 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79187023 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78775638 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78443076 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.77363636 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74832062 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72516756 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72158787 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70555371 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69710683 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68661467 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68506353 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.67970952 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67354716 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66276333 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64195011 |
| 114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63609487 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62934449 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62404336 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61678453 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.61336300 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.61272070 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60579531 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.60344562 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58625121 |
| 123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57924812 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57643827 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56701974 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56364139 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55271653 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53996193 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53463468 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51451264 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51278614 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50820749 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.50009104 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49918995 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49682514 |
| 136 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48305390 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.47811278 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46721620 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45707521 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.42239585 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40431733 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.38717897 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35053285 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34821254 |
| 145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33109358 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30885128 |
| 147 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30231993 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30037699 |
| 149 | Insulin secretion_Homo sapiens_hsa04911 | 0.29173281 |
| 150 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28851430 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26400005 |
| 152 | Morphine addiction_Homo sapiens_hsa05032 | 0.25228794 |
| 153 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.22697515 |
| 154 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21339891 |
| 155 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.20387211 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.19808498 |
| 157 | Lysosome_Homo sapiens_hsa04142 | 0.19641061 |
| 158 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18699208 |
| 159 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17412772 |
| 160 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17347836 |
| 161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.15965399 |
| 162 | Nicotine addiction_Homo sapiens_hsa05033 | 0.13326271 |
| 163 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11777966 |
| 164 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.11252042 |
| 165 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.11008640 |
| 166 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10608772 |
| 167 | Circadian entrainment_Homo sapiens_hsa04713 | 0.10362271 |
| 168 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.09765367 |
| 169 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.09672295 |
| 170 | Other glycan degradation_Homo sapiens_hsa00511 | 0.07288816 |
| 171 | Cocaine addiction_Homo sapiens_hsa05030 | 0.05427588 |
| 172 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04632737 |

